Drug for treatment of jaundice and preparation method thereof

Abstract

The invention discloses a drug for treatment of jaundice and a preparation method thereof, wherein the drug comprises the raw materials in parts by weight: 30-200 parts of herba artemisiae capillariae, 50-200 parts of wrinkled gianthyssop herb, 30-200 parts of radix salviae miltiorrhizae, 10-150 parts of liquorice, 5-40 parts of radix gentianae, 5-40 parts of semen alpiniae katsumadai, 30-200 parts of radix angelica sinensis, 10-150 parts of fructus aurantii, 30-200 parts of cortex albiziae, 200-600 parts of herba portulacae, 50-300 parts of humifuse euphorbia herb, 10-150 parts of radix curcumae, 100-650 parts of herba lysimachiae, 5-30 parts of fennel, 1-20 parts of pine nodular branch, 1-20 parts of radix bupleuri, and 100-450 parts of minium. The preparation method comprises the steps:crushing the raw materials into a coarse powder; decocting for 2 times with water having the amount 5-20 times of the total weight of the raw materials, merging filtrates, concentrating, then addingminium, stirring evenly, and thus obtaining the drug. The drug has the advantages of no toxic or side effects, safe use, consideration of both primary and secondary symptoms, good curative effect, high effective rate, short course of treatment, total effective rate of 100%, and cure rate of 85% or more, and can cure general neonatal jaundice in 3-10 days.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating jaundice and a preparation method thereof. Background technique [0002] Jaundice is a common symptom and sign, and its occurrence is caused by the increase of serum bilirubin concentration due to bilirubin metabolism disorder. Clinically, the sclera, mucous membranes, skin and other tissues are stained yellow. Because the sclera contains more elastin and has a strong affinity with bilirubin, yellow staining of the sclera in patients with jaundice is often noticed before the mucous membrane and skin. When the serum total bilirubin is 17.1-34.2 μmol / L, but no jaundice can be seen with the naked eye, it is called recessive jaundice or subclinical jaundice; when the blood stain total bilirubin concentration exceeds 34.2 μmol / L, it can be detected clinically Jaundice, also known as overt jaundice. At present, phototherapy is mostly used in the treatment of...

AI Technical Summary

Problems solved by technology

At present, phototherapy is mostly used in the treatment of jaundice, but it is difficult to widely promote it.

In conventional drug treatment, it is stubborn, has large side effects, takes a long time and recurs, and most of them are addictive. The relapse rate is high after drug withdrawal, and it cannot be cured